Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Sunesis Pharmaceuticals, Inc.

NASDAQ: SNSSHealthcare / Biotechnology / USA
0.4700-0.1200-20.34%Vol 3 202 9481Y Perf -87.84%
Jan 18th, 2019 16:00
BID0.4900 ASK0.5100
Open0.5000 Previous Close0.5900
Pre-Market0.52 After-Trading0.50
 -0.07 -11.86%  0.03 6.38%
Target Price
5.17 
Analyst Rating
Moderate Buy 2.00
Potencial %
1 000.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
     38.06
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)18 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
3.60 
Earnings Date
14th Mar 2019

Today's Price Range

0.47000.5400

 

52wk Range

0.20007.69

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
46.88%
3 Months
-73.45%
6 Months
-80.50%
1 Year
-87.84%
3 Years
-90.45%
5 Years
-98.37%

Quotes

Name / TickerPriceChg.Chg.%
SNSS0.4700-0.1200-20.34
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.60
Current Ratio
1.70
Long Term Debt to Total Capital
-
Total Debt to Equity
12.46
Interest Coverage
-22.90
Leverage Ratio -2.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-11 013.50
EBITDA Margin
-11 010.10
Pre-tax Profit Margin
-2 809.50
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
171.26
PS Ratios
116.04
Price to Cash Flow
-
Price to Free Cash Flow
-1.50
Cash Flow Per Share
-0.62
Price to Tangible Book
-2.36
Book Value per Share
-0.31
Enterprise Value (in ths.)
35 653
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-694.48
ROE last 12 Months
215.30
Return on Assets (5Y Avg)
-204.90
ROA last 12 Months
-148.64
Return on Capital (5Y Avg)
-333.57
ROC last 12 Months
-156.07
Return on invested Capital Q
-
Return on invested Capital Y
-511.02
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
237
Revenue per Share
0.01
Revenue Growth 3 Years
-53.89
Revenue Growth 5 Years
-46.90
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.24-0.1825.00
Q02 2018-0.26-0.2023.08
Q01 2018-0.29-0.2127.59
Q04 2017-0.25-0.2116.00
Q03 2017-0.37-0.43-16.22
Q02 2017-0.76-0.4146.05
Q01 2017-0.83-0.4743.37
Q04 2016-0.38-0.44-15.79
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.2212.00Positive
12/2018 FY-0.818.99Positive
3/2019 QR-0.253.85Positive
12/2019 FY-0.9220.00Positive
Next Report Date14th Mar 2019
Estimated EPS Next Report-0.22
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume3 202 948
Shares Outstanding (in ths.)37 422
Trades Count2 482
Dollar Volume1 588 415
Avg. Volume555 039
Avg. Weekly Volume681 922
Avg. Monthly Volume644 630
Avg. Quarterly Volume406 947

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

45%55%

Bearish Bullish

60%40%

Bearish Bullish

53%48%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News